Eam Global Investors LLC Voyager Therapeutics, Inc. Transaction History

Eam Global Investors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$4.82 - $10.09 $1.08 Million - $2.27 Million	-224,825 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$2.75 - $9.44 $618,268 - $2.12 Million	224,825 New	224,825 $1.71 Million
Q3 2019 Nov 13, 2019	SELL	$16.31 - $28.29 $813,510 - $1.41 Million	-49,878 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$19.18 - $27.88 $956,660 - $1.39 Million	49,878 New	49,878 $1.36 Million
Q2 2018 Aug 03, 2018	SELL	$16.76 - $23.92 $603,980 - $862,005	-36,037 Closed	0 $0
Q1 2018 Jun 04, 2018	BUY	$16.16 - $31.31 $582,357 - $1.13 Million	36,037 New	36,037 $677,000

130

34.7M

39.7K

34.6K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $210M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Global Investors LLC with notifications on news.